546 — Medtecs International Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual income statement for Medtecs International, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	400	144	56.2	52.6	54.4
Cost of Revenue
Gross Profit	172	42	-3.34	6.52	6.92
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	264	126	86.9	75.6	66.5
Operating Profit	137	17.8	-30.6	-23	-12
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	135	16.9	-30.7	-22.5	-23.4
Provision for Income Taxes
Net Income After Taxes	132	16.5	-29.3	-22.5	-23.9
Minority Interest
Net Income Before Extraordinary Items
Net Income	132	17.3	-28.6	-21.1	-22.4
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	132	17.3	-28.6	-21.1	-22.4
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.24	0.032	-0.053	-0.038	-0.041
Dividends per Share